Ginny Lynn Schulz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Summary
- Areas of interest: pediatric stem cell transplant in nonmalignant disease; family and pediatric treatment decision-making; and impact of psychosocial factors on stem cell transplant outcomes
Certifications & Licensure
- Pediatric Nursing Certification Board Pediatric Nurse Practitioner Primary Care
- Association of Pediatric Hematology/Oncology NursesChemotherapy/Biotherapy Provider
Hospital Affiliations
- St. Louis Children's HospitalSaint Louis, Missouri
Education & Training
- University of MissouriPhD candidate, Nursing, 2013
- University of North CarolinaCertificate, Family Research Institute: Conceptual and Methodological Issues, 2016
- University of MissouriMSN, Nursing; Pediatric Nurse Practitioner, 2011
- University of MissouriBSN, Nursing, 2006
- University of MissouriPost-Masters Certificate
Awards, Honors, & Recognition
- Awarded PhD Student Award in Overall Excellence University of Missouri-Columbia, 2017
- Nominee for Graduate Leadership Development Program University of Missouri-Columbia, 2016
- Awarded V. James & Verna Adwell Rhodes Endowed Nursing Fellowship University of Missouri-Columbia, 2014
- Join now to see all
Professional Memberships
- Member
- Children's Oncology GroupMember
- Association of Pediatric Hematology/Oncology NursingMember
- Nurse Scholars, Children's Oncology GroupMember
- International Family Nursing AssociationMember
- Society of Medical Decision-MakingMember
Publications & Presentations
PubMed
- 11 citationsImmune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric PatientsSima T. Bhatt, Jeffrey J. Bednarski, Julia Berg, Kathryn Trinkaus, Lisa Murray, Robert J. Hayashi, Ginny Schulz, Monica Hente, Michael Grimley, Ka Wah Chan, Naynesh Ka...> ;Biology of Blood and Marrow Transplantation. 2019 Mar 1
- 1 citationsEarly Identification of Barriers and Facilitators to Self-Management Behaviors in Pediatric Patients With Sickle Cell Disease to Minimize Hematopoietic Cell Transplant...Ginny Schulz, Rebecca H. Foster, Valerie Kennedy Lang, Alison Towerman, Shalini Shenoy, Brea-Anne Lauer, Elizabeth Molzon, Megan Holtmann> ;Journal of Pediatric Oncology Nursing. 2018 Mar 26
Journal Articles
- Sickle cell disease and hematopoietic stem cell transplantation: Exploring alternative donorsSchulz, G, APHON Counts, 2015
- Evidence-based practice recommendations for hydration in children and adolescents with cancer receiving intravenous CyclophosphamideRobinson, D., Schulz, G., Langley, R., Donze, K., Winchester, K., & Rodgers, C., Journal of Pediatric Oncology Nursing, 2014
Abstracts/Posters
- A single center experience using alemtuzumab, fludarabine, melphlan, and thiotepa as conditioning for transplant in chronic granulomatous diseaseBhatt, S., Schulz, G., Shenoy, S., & Bednarski, J. J., BMT Tandem Meeting, American Society for Blood and Marrow Transplantation, 2/2017
- Describing psychosocial barrier to minimize stem cell transplant complications in pediatric patients with sickle cell disease: A case study approach.Schulz, G., Foster, R., Kennedy, V., Towerman, Alison., Holtmann, M. (, BMT Tandem Meeting, American Society for Blood and Marrow Transplantation, 2/2017
- The comparison of 100 day chimerism in pediatric nonmalignant allogeneic stem cell transplant patients receiving subcutaneous versus intravenous Alemtuzumab: One Insti...Langley, R. C., Schulz, G., Bednarski, J. J., & Hente, M. L., APHON Conference Association of Pediatric Hematology/Oncology Nurses, 9/2016
- Join now to see all
Grant Support
- Decision Making in Pursuing Hematopoietic Stem Cell TransplantationAmerican Cancer Society2017–2019
- Understanding Decisional Conflict in Families of Children and Adolescents with Sickle Cell Disease: Should We Choose Hematopoietic Cell Transplant?MU Patient-Centered Outcomes Research Institute2017–2018
- Decision Making in Pursuing Hematopoietic Stem Cell TransplantationAmerican Cancer Society2015–2017
Office
660 South Euclid
Campus Box 8116
Saint Louis, MO 63110Phone+1 314-454-6018Fax+1 314-454-2780- Is this information wrong?
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: